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Radionuclide Injury to the Lung
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Radionuclide injury to the lung has been studied in rats, hamsters, dogs, mice and baboons. Exposure of
the lung to high dose levels of radionuclides produces a spectrum of progressively more severe functional
and morphological changes, ranging from radiation pneumonitis and fibrosis to lung tumors. These
changes are somewhat similar for different species. Their severity can be related to the absorbed radiation
dose (measured in rads) produced by alpha, beta or gamma radiation emanating from various deposited
radionuclides. The chemicophysical forms ofradionuclides and spatial-temporal factors are also important
variables. As with other forms of injury to the lung, repair attempts are highlighted by fibrosis and
proliferation ofpulmonary epithelium. Lung tumors are the principal late effect observed in experimental
animals following pulmonary deposition of radionuclides at dose levels that do not result in early deaths
from radiation pneumonitis or fibrosis. The predominant lung tumors described have been of epithelial
origin and have been classified, in decreasing frequency of occurrence, as adenocarcinoma, bronchiolo-
alveolarcarcinoma, epidermoid carcinomas and combined epidermoid and adenocarcinoma. Mesothelioma
and fibrosarcoma have been observed in rats, but less commonly in other species. Hemangiosarcomas were
frequency observed in dogs exposed to beta-gamma emitters, and occasionally in rats exposed to alpha
emitters. These morphologic changes in the lungs of experimental animals were reviewed and issues
relevant to the prediction of human hazards discussed.
Introduction
Inhalation of radionuclides constitutes a potential
health hazard to selected occupational groups in the
nuclear industry and to the general public from nuclear
weapons testing. The association ofpulmonary radionu-
clide exposure and lung cancer has been documented in
uranium and fluorspar miners (1-3). Since few human
data exist, however, with respect to biological effects
frominhaled transuraniumradionuclides orfission prod-
ucts derived from the nuclear industry, dose-effect
studies in experimental animals have been performed in
order to predict the health consequences in humans
from inhalation ofthese products. Literature reviews on
the pulmonary toxicity of inhaled radionuclides have
been presented by -Bair and Thomas (4), Bair and
Thompson (5), ICRP (6), the Medical Research Council
(7) and Thompson (8). This paper reviews the morpho-
logic changes in the lungs of experimental animals
produced by the inhalation of radionuclides and points
out some issues relevant to the prediction of human
health hazards.
Models for the deposition and retention of radio-
nuclides, based on the anatomy ofthe respiratory tract,
particle size and solubility of the radionuclides, have
been presented by the ICRP (9). Deposition was
separated into the following major compartments:
nasopharyngeal, tracheobronchial, pulmonary (alveo-
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lar), and thoracic lymph nodes. The fraction of inhaled
aerosol particles deposited in the various regions ofthe
respiratory tract was determined as a function of
particle size. Particles deposited on the mucus layer of
the nasopharyngeal and tracheobronchial regions are
cleared, in minutes to hours, by cilia-propelled mucus
flow. Particles deposited in the pulmonary region may
be phagocytized by alveolar macrophages or by Type I
alveolar epithelium, or they may be solubilized, either
free in the air space or within macrophages and/or
epithelium. Macrophages with engulfed particles may
then migrate to the ciliated portions of the respiratory
tract and be cleared, whereas soluble particles may pass
through the alveolarwallinto bloodstreamfortransport
to extrapulmonary tissues. Radionuclides cleared by
the mucociliary escalator may be swallowed and then
either absorbed from the gastrointestinal tract or
passed in feces. Radionuclides absorbed into the blood-
stream may be excreted via urine or bile. Bronchial and
tracheobronchial lymph nodes may also accumulate a
considerable amount of radionuclides.
Retention of inhaled radionuclides in the lung is
primarily dependent on the chemical form of the
compound. The ICRP (9) postulates D, W and Y class
compounds having average clearance times from the
lung of0.5 50 or 500 days, respectively. Animal studies
have shown that oxides of plutonium, americium, and
curiumhave pulmonary clearance timesrangingfrom 50
to 1000 days. Actinide nitrates and other soluble
chemical forms have more rapid pulmonary clearance
rates. Oxidation temperature may also influence theDAGLE AND SANDERS
clearance of oxides, i.e., high-temperature oxidation
forms more insoluble compounds.
Retention of radionuclides in the lung is also influ-
enced by particle size and specific activity. The specific
activity is related to the amount ofenergy released per
unit mass of the radionuclide, with faster decay rates
yielding higher specific energies. Increased particle
size, higher specific activities, and increased quantity of
material deposited in the lung will cause increased
cytotoxicity to macrophages phagocytizing particles.
Increased macrophage cytotoxicity is associated with
fibrosis that tends to sequester particles in the lung,
causing longer retention times. Increased specific
activity, however, can influence physicochemical proper-
ties of compounds, causing "dissolution" and increased
solubility, resulting in shorter retention time in the
lung.
The absorbed radiation dose, measured in rad (1 rad
= 100 erg/g oflung), can be calculated after determin-
ing deposition levels and clearance curves for the
radionuclide. Although the absorbed radiation dose is
important in making comparisons between radionu-
clides, the magnitude of biological effects is more
closely related to the average energy released per unit
track length (termed the linear energy transfer, or
LET). For example, alpha particles, generally having
track lengths of approximately 40 ,um, have much
higher LET than beta particles having track lengths
extending several millimeters in tissues.
The spatial-temporal considerations are also impor-
tant in radionuclide toxicology. For example, the aver-
age radiation dose to the lung, measured in rad, does
not reflect the possibility of nonuniform distribution.
Very high amounts of energy released in the area of a
few cells could have less biological effect, due to wasted
energy, than if this energy were distributed over the
entire lung. Factors such as lung cell movements,
particle movements, solubility, and particle size tend to
average the dose-distribution pattern in the lung for
inhaled radionuclides from the initial nonhomogeneous
pattern to a more homogeneous one. The degree ofdose
nonhomogeneity is greaterforinsoluble, alpha-emitting
transuranic oxides than for more soluble transuranics
or for beta-gamma emitters. A comprehensive assess-
ment of radiation dose from inhaled plutonium, how-
ever, indicated that averaging the absorbed alpha radi-
ation dose provided a sound basis for predicting health
hazards (10).
Types of Injury
General
Exposure of the lung to high dose levels of radio-
nuclides produces a spectrum of progressively more
severe functional and morphological changes, ranging
from radiation pneumonitis and fibrosis to lung tumors.
These changes are somewhat similar for different
species. Their severity can be related to the radiation
dose produced by the alpha, beta or gamma radiations
emanating from various deposited radionuclides (11,
12). As with other forms of injury to the lung, repair
attempts are highlighted by fibrosis and proliferation
ofpulmonary epithelium. Lungtumors are the principal
late effect observed in experimental animals following
pulmonary deposition of radionuclides at dose levels
that do not result in early deaths from radiation
pneumonitis or fibrosis.
Replicating cells may be more susceptible to cancer
formation than resting cells. In the rat, the alveoli
continue to multiply throughout life; bronchiolar and
alveolar epithelium turn over every 30 days or less (13,
14). Mechanical irritation; chemical, physical, and
infectious agents; and vitamin A deficiency may result
in squamous cell and adenomatous metaplasia in the
lung (15,16). Continuous irritation to the lung may
provide the promotional stimulus needed for develop-
ment of lung tumors (17).
The concept of progression in neoplasms was evalu-
ated by Foulds (18). According to Saccomanno et al.
(19), the properties ofa tumor cell are acquired serially
inakindofcellularevolution. Mechanisms haveprobably
evolved to protect the body fromthe evolution ofaltered
cells in rapidly regenerating epithelial tissues. It may
be necessary for a certain number of cells to form a
malignant "focus"beforetumorgrowth occurs inthe lung
(20, 21). There appears to be arelationship between the
incidence of radiation-induced tumors in the lung and
ionizing events in each cell, multiplied by the number of
cells irradiated in the lung (22,23).
Rats
The rat's susceptibility to injury from inhaled radio-
nuclide, along with its ready availability, small size and
short lifespan, have contributed to its popularity for
studying the inhalation hazards of radionuclides. In
addition to being used to study basic mechanisms
involved in reaction to injury, an abundant amount of
data have accumulated on the relative toxicity of
different radionuclides in rats. Pour et al. (24) described
the various types ofspontaneous and induced tumors in
the lungs ofrats. Rats rarely develop spontaneous lung
tumors, except for lymphoreticular neoplasms, which
may be confused with chronic murine pneumonia.
Epithelial tumors ofthe lunginrats have been classified
asadenocarcinoma, bronchioloalveolarcarcinoma, undif-
ferentiated carcinoma, anaplastic carcinoma, well differ-
entiated carcinoma or squamous cell carcinoma. Fol-
lowing exposure to transuranics, most induced lung
tumors are well-differentiated adenocarcinomas and
squamous cell carcinoma. Hemangiosarcoma, fibrosar-
coma, and mesothelioma are less frequently observed
following exposure to transuranics.
Stuart et al. (25) evaluated the acute effects of
inhaled plutonium dioxide. Rats exposed to very high
doses of238PuO2 or239PuO2 (6 to 20 puCi/g oflung) died,
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with severe pulmonary edema, as early as 6 to 7 days
after exposure. At lower doses (- 0.2,Ci/g) survival
was longer, with less alveolar edema and deposition of
fibrin, but with early proliferation ofbronchiolar and al-
veolarepithelium. Thephagocytosis ofinhaledplutonium
particles has been documented in alveolar macrophages
(26-29) and in alveolar Type I cells of rats (29).
In rats exposed to inhaled 239PuO2 (30), a progressive
radiation pneumonitis developed. It was characterized
by damage to pulmonary endothelium and septal wall
thickening, caused by interstitial accumulation of
collagen and elastin. Pulmonary connective tissue
modifications inratsafterinhalationof239PuO2have also
beenstudied (31). Biochemical determination ofprotein,
collagen, and uranic acids were related to dose and
time. Increased collagen content in the lung was
maximal at 200 days after exposure, but returned to
pre-exposure values after 400 days in rats receiving the
same total rad dose. Since histological examination
showed no observable decrease in focal scars between
200 and 400 days after exposure, it was concluded that
the decrease in connective tissue components observed
with biochemical methods at 400 days after exposure
must be correlated with a fine, diffusely distributed
connective tissue alteration.
Adenocarcinomas are the lungtumormostfrequently
seen in rats exposed to alpha emitters such as 9PuO2
(32,33) and 21PuO2 (34). Adenomatous metaplasia and
adenomas appeared to precede the development of
malignant tumors, suggesting that these lesions may be
precursors ofmalignancy. The adenomatous metaplasia
consisted of cuboidal epithelial cells lining groups of
alveoli and alveolar ducts. With adenomas there was an
irregularproliferationofcuboidalepithelialcellsforming
papillary patterns, replacing the normal architecture of
thepulmonaryparenchyma. Themalignantdesignation,
adenocarcinoma, was reserved for tumors that invaded
pleura, blood or lymphatic vessels; invaded other
nonparenchymal tissues; metastasized; or histologically
resembled invasive or metastatic tumors. Adenocar-
cinomas generally arose in peripheral areas (frequently
subpleural or peribronchiolar) and were associated with
areas exposed to high doses ofradiation (35), but were
not always associated with fibrosis. Mucus production
by tumor cells was seen in about a third of the tumors
(PAS-positive stains). Ultrastructural studies indicated
that few tumors arose from lrype II pneumocytes. Most
tumors appeared to originate from bronchiolar epi-
thelium, presumably in terminal regions, and ultra-
structurally resembled bronchiolar Clara cells. Meta-
stases were observed within the mediastinum, and
occasionally to kidney. Metastasis to kidney and/or
lymph nodes was more frequent in Fischer strain than
in Wistar strain rats.
Epidermoid carcinomas in rats consisted ofirregular
proliferation of stratified squamous keratinizing epi-
thelium, often replacing entire lobes. Foci of squamous
metaplasia frequently occurred in association with
radiation-induced fibrosis prior to the appearance of
lung tumors. Squamous metaplasia and neoplasia were
more frequently associated with areas of radiation
fibrosis than were adenocarcinomas. Epidermoid car-
cinomas in rats were more likely to metastasize to
distant sites such as kidney. Occasionally, rats developed
other primary epidermoid carcinomas and adenocar-
cinomas.
Hemangiosarcomas were also seen after inhalation
oftransuranics, more frequently with239PuO2than with
238PuO2 or other radionuclides. Hemangiosarcomas,
which arose from central regions ofthe lung, comprised
large solitary masses, composed of dilated vascular
spaces, filled with blood and large thrombi, and lined
with endothelial cells. The tumors may have originated
from venous-arterial shunts associated with radiation-
induced scar tissue; they often filled large areas oflobes
and contained anaplastic endothelial cells. Metastasis,
however, did not occur.
Malignant mesotheliomas grew from the pleural
surface, often into large areas ofthe pleural cavity, and
occasionally were implanted in the heart. The tumors
had papillary patterns with cuboidal epithelial cells, or
combined spindle cell and epithelial patterns. Meso-
theliomas induced in rats by intraperitoneally admin-
istered "9PuO2 have been extensively studied. They
were similar in morphogenesis and origin to meso-
theliomas induced by intraperitoneal injections of
chrysotile asbestos (36).
The spectrum of radionuclide-induced lung tumors
observed in rats, as described above, is similar to that
observed after inhalation of soluble plutonium (37),
radon-222 and its daughter products (38) 239Pu (39),
'Am (39), 24CmO2 (40), 243EsC13 (41), 2ldPo (42), and
144CeO2 (43). Differences in radiation dose and dose
distribution, however, altered the types of tumors
produced. Squamous cell carcinomas predominated at
high doses of insoluble 21PuO2 or 211PuO2 particles;
adenocarcinomas predominated at lower doses. For
more soluble transuranics, such as 44CmO2 and soluble
238Pu, adenocarcinoma predominated at all doses. A
series of studies with beta- and gamma-emitting
radionuclides implanted by various means into the lung
produced squamous cell carcinomas (44).
Inanotherseries ofstudies, Wistarratswere exposed
to aerosols of 23PuO2, 239PuO2 or 244CmO2 (33). Al-
veolar depositions oftransuranics ranged from approx-
imately 0.1 nCi to 1000 nCi. No lung tumors were found
in 230 unexposed rats. Thirty-three lung tumors were
found in 294 rats exposed to high-fired 3PuO2; 16 lung
tumors were found in 92 rats exposed to 238PuO2
producedfromcrushedmicrospheresinsalineforseveral
months prior to exposure; 56 lung tumors were found in
295 rats exposed to high-fired 239u02; 12 lung tumors
were found in 61 rats exposed to air-oxidized 39PuO2;
and 23 lung tumors were found in 240 rats exposed to
high-fired 44nCO2. Astatistically significantincreasein
the incidence of lung cancer was calculated at an
estimated radiation dose to the lung of56 rad for238Pu,
32 rad for 238pu, 78 rad for 239Pu, 50 rad for 239Pu and
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27 rad for 244CmO2. In each study, individual rats
developed lung tumors at lung doses ofless than 10 rad.
The incidence oflungtumors at these low doses was not
significantly different from that ofcontrols, but tumors
were consistently found.
The type of induced lung cancer was a function of
dose-distribution patterns (33). Further analyses of
risk were performed on published data, consisting of
radiation dose to lung and percent oflung tumors taken
from 19 lifespan studies in over 5000 rats given a single
inhalation exposure to alpha-emitting radionuclides.
The data were analyzed in three groups: (1) plutonium
oxides and nitrates; (2) plutonium citrate and ammo-
nium plutonium pentacarbonate; and (3) americium,
curium, and einsteinium nitrates and oxides. The
spontaneous lung tumor incidence for unexposed rats
was 0.14% (based on one observed tumor). The predicted
total percent of lung tumors at 1.5 rad to lung was
usually between 0.3 and 0.7% for all groups; none ofthe
groups gave a predicted value statistically different
from that of the other groups.
Studies on the histogenesis oflung tumors induced in
rats by inhalation of alpha emitters have recently been
reviewed by Masse (45). These investigators divided
adenocarcinomas into two main types: bronchogenic (B)
and bronchioloalveolar (BA) carcinomas. Ultrastruc-
turally, the B tumors were characterized by irregular
nuclei, a developed complex of rough endoplasmic
reticulum, often filled with electron-lucent material,
mucus granules, conspicuous desmosomes, and, under
the apical edge, bunches of filaments with slender
microvilli. In an adenoacanthoma variety, there were
intracellular spaces similar to those observed in humans
by McDowell et al. (46), but few mucous granules.
When two B tumors were transplanted, epidermoid
differentiation was observed, with loss ofthe glandular
pattern.
The BAtumorsdescribed byMasse exhibitedpapillary
growth spreading along the margin, were peripherally
located, and exhibited early invasion of pleura and
mediastinum. Although some BA tumors were mucus-
secreting, none exhibited epidermoid differentiation on
metastasis or transplantation. The cells were columnar
or cuboidal, and the nuclei appeared round oroval, with
membrane infolding. Ultrastructurally, apical bunches
of filaments were lacking, desmosomes were not con-
spicuous, and there was no protrusion of the apex into
the cytoplasm. The lamellar bodies identified in 37% of
BA tumors indicated that they were derived from 'rype
II pneumocytes. Other BA tumors were thought to
originate from Clara cells.
Hamsters
The Syrian golden hamster has a low incidence of
spontaneously occurring lung tumors (24). In addition,
the hamster is considered to be resistant to pulmonary
infections (15,47). There appear to be some species
differences between rats and hamsters with respect to
pulmonary carcinogenesis from inhaled radionuclides.
Moreover, there appears to be a significant difference in
the susceptibility ofthe hamster to pulmonary carcino-
genesis by inhalation versus that from serial intra-
tracheal instillation of radionuclides on "inert" carrier
particles. Inhalation of alpha emitters (239Pu) produced
few lung tumors in hamsters (48), whereas intra-
tracheal instillation of alpha-emitters (210po) in saline
resulted in numerous lung tumors at low doses (49,50).
This indicated that both spatial-temporal dose dis-
tribution patterns and apparently innocuous stimuli
such as saline may greatly influence pulmonary carcin-
ogenesis (51-53).
Altered collagen metabolism in plutonium-induced
interstitial pulmonary fibrosis has been studied in the
hamster (54). A similar study in hamsters that inhaled
beta or gamma emitters showed both synthesis and
degradation of collagen within a 2-week period and
histologically observed fibrosis by 2 months after
exposure (55). Autoradiographic studies showed that
collagen stain observed on tissue slides accumulated
preferentially in areas immediately surrounding in-
dividual plutonium particles and in regions of high
particle concentration (56).
An incidence of lung tumors in hamsters of as much
as 92% was seen at lung doses of 4500 rad, and 43% at
225radfollowinginstillations of210pooncarrierparticles
of ferric oxide (57). This method of pulmonary deposi-
tion produced the greatest radiation dose in the
bronchiolo-alveolar region, the region where the tumors
arose. The tumors, observed by light microscopy, had
features of both epidermoid and adenocarcinomas, and
were therefore classified as "combined tumors:' In an
elegant histochemical, light and electron microscopy
study of hamsters exposed to 210Po and serially
sacrificed, the bronchiolar Clara cell was identified as
the probable cell of origin of these lung tumors (58). A
rapid progression from hyperplasia to bronchiolar-cell
malignant tumors was described (59).
Other investigators have shown that hamsters are
refractory to the induction of lung tumors with radio-
nuclides. Inaseriesofstudiesin Syriangoldenhamsters
exposed to the inhalation of radon daughters and
uranium ore dust (60), lung tumors developed in only a
few hamsters, and only in those animals receiving very
high dose levels. The uranium ore dust induced inflam-
matoryandproliferativechangesinthelungs, consisting
of macrophage accumulation, alveolar cell hyperplasia,
and adenomatous lesions which did not progress to
tumors. Exposure to radon and radon daughters was
associated with bronchiolar epithelial hyperplasia, and
metaplastic changes of alveolar epithelium. Squamous
carcinoma developed in four hamsters, with incidences
ofapproximately 3% ofhamsters exposed to radon and
radon daughters, and 1% of hamsters exposed to
radon and radon daughters plus uranium ore dust.
The development of squamous metaplasia and develop-
ment ofcarcinoma were considered related. Because of
the very low incidence of lung cancer resulting fromRADIONUCLIDE INJURY TO THE LUNG
exposure to radon and radon daughters, it was con-
cluded that an animal model "other than the hamster
would be more appropriate for study of the pulmonary
carcinogenic potential of uranium ore alone'
In order to make a comparison of pulmonary carcin-
ogenesis between rats and Syrian golden hamsters,
hamsters were exposed by inhalation to 239PuO2 or
238PuO2 at doses that caused lung tumors in rats.
Hobbs et al. (61), using 239PuO2, and Mewhinney et al.
(62), using 238PuO2, did not observe lung tumors.
Sanders (48) reported a lung tumor incidence of3 in 292
Syriangoldenhamsters thatinhaled238PuO2 or239PuO2.
Although, in hamsters, the inhaled plutonium produced
a dose-dependent increase in adenomatosis that could
be considered premalignant, the adenomatosis lacked
histopathologic criteria for malignancy, and did not
affect mortality. Several investigators have described
the development ofadenomatosis in the lungs following
treatment with a chemical carcinogen (63-66). However,
the lack of association between adenomatosis and
carcinoma transformation in hamster lungs indicates
that either adenomatous metaplasia is not a step in the
pathogenesis of pulmonary carcinoma; that a biological
control mechanism prevents or inhibits the progress of
adenomatous metaplasia into carcinoma; or that a
prolonged latent period exists between the appearance
of metaplasia and neoplasia, extending beyond the
lifespan of the hamster strain used in these studies.
In an imaginative series of studies at Los Alamos
Scientific Laboratories, Syrian golden hamsters were
intravenously injected with microspheres of 10 ,um
diameter containing Pu and ZrO2 ceramic (51, 67, 68).
The microspheres lodged in the pulmonary capillaries
and remained immobile for the life of the hamster.
Because of the immobility and the uniformity of the
microsphere distribution, radiation doses were very
precisely quantified. Tothesurprise oftheinvestigators,
veryfewtumorswere observed. Studieswithconcurrent
intratracheal injections of ferric oxide, however, raised
the incidence of primary lung tumors from 5% to 38%
(53). Similarly, intravenously injected microspheres
exposing hamsters to 147Pm beta radiation produced
lung adenomas, adenocarcinomas, and epidermoid
carcinomas, reaching a 30% incidence at a very high
dose rate (15 rad/year); the adenomatous.bronchiolar
lesion was described as an unreliable estimator of
tumorigenicity (51). From the work with intravenously
injected microspheres, it can be concluded that factors
other than radiation are involved in pulmonary car-
cinogenicity.
Dogs
Dogs are the most common, large, nonrodent, labor-
atory animal used in inhaled radionuclide studies.
Advantages of dogs over rodents include their longer
lifespan, which allows translation of radionuclides to
extrapulmonary organs, a lung function with respect to
inhaled particles that more closely resembles the
human, and a greater similarity to humans in some
aspects of radionuclide kinetics (69).
Thelunghistopathologyfollowingexposureto239PuO2,
238PuO2, and 239Pu(NO3)4 appeared to be similar for
comparable radiation doses from these various chemical
and physical forms of plutonium (70). Alveolar depo-
sitions of239PuO2 in amounts of0.1 ,uCi/g oflung tissue
was associated with respiratory failure within 10
months, characterized as pulmonary edema, severe
vascular damage, fibrinous accumulations in bronch-
ioles and alveoli, and pulmonary fibrosis. Alveolar
deposition in the range of 0.05 ,uCi/g of lung induced
pulmonary fibrosis, bronchioloalveolar cell hyperplasia
andmetaplasia, alveolarhistiocyte proliferation, pleural
fibrosis and early "alveolar tumor formation" in 1 to 5
years. In an additional study comparing plutonium-239
and -238 dioxide, lung lesions were related to total
cumulative dose (71). Autoradiographic studies have
shown the plutonium particles to be concentrated in
areas of fibrosis (72).
Bronchioloalveolar tumors were first described in
four dogs surviving more than 855 days after inhalation
of239PuO2, with lung burdens at death of0.6 to 1.4 ,uCi
(73). The lungs ofthese animals had marked amounts of
radiation pneumonitis, characterized as diffuse fibrosis,
sclerosis, and, in some instances, hyalinized areas in
subpleural, septal, and peripheral regions. The authors
described a gradual transition from alveolar metaplasia
to more anaplastic and, finally, neoplastic forms. The
tumors were described as follows: "Infiltrating pleo-.
morphic cells in these regions assumed epithelioid or
squamous characteristics, formed frondlike papillary
projections, or took the appearance of bronchiolar or
acinar structures."
Bronchioloalveolar carcinomas were described indogs
from additional ongoing studies with inhaled 239PuO2
(74,75). The morphology of 239PuO2-induced tumors in
22 dogs were later described (70) as mostly bronchio-
loalveolar carcinomas of peripheral origin, with two
peripheral squamous cell carcinomas and three epider-
moid carcinomas. Metastases were often demonstrated
in the tracheobronchial and mediastinal lymph nodes
and, less often, in the mesenteric lymph nodes, liver,
kidney, spleen, adrenals, brain, and bone marrow. The
high incidence ofprimary lung tumors was emphasized
in a later paper (76), which reported that 20 of 21 dogs
developedpulmonaryneoplasia
- 4.5yearsafterasingle
inhalation exposure to 23 pU02, with estimated average
cumulative radiation dose to the lungs of2,000 to 12,000
rad. Using Cutler-Ederer estimates of lung tumor
incidence, adjusted for differences in proportional
survival, a higher incidence oflung tumors was found in
dogs than in rats at earlier times in proportion to their
life expectancy. The incidence was significantly higher
in the interval from 20% to 50% of lifespan (77). Dogs
also had a proportionately earlier mean time to tumor
occurrence.
The inhalation of beta-gamma emitters produced a
slightly different spectrum of changes from those
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produced by alpha-emitting plutonium. The effects of
aerosols ofrelatively soluble orinsoluble beta orgamma
emitters having different radioactive half-lives are being
studlied to determine the effects ofvarious dose patterns
(78,79). Yttrium-90, 91Y, 144Ce and 90Sr were fused in
aluminosilicate to form particles that were more slowly
cleared from the lung. Deaths from radiation pneumon-
itis and pulmonary fibrosis, similar to those seen after
inhalation of high dose levels of plutonium, were seen
within the first 500 days after exposure. Survival time
appeared to be a function of dose rate.
Changes in collagen constituents in different regions
of lung were studied in beagle dogs after inhalation of
beta-emitting radionuclides (80). Measurements of
insoluble native collagen, soluble collagen (tropocol-
lagen or procollagen), and ultrafilterable hydroxyproline
peptides indicated that the development of pulmonary
fibrosis was directly related to initial dose rate in the
lung. The pathogenesis of pulmonary fibrosis following
inhalation ofradionuclides seemed to be: initial collagen
degradation, followved by increased synthesis and ac-
cumulation of collagen and, finally, a more normal rate
ofsynthesis and, possibly, degradation. Previousstudies
by Pickrell et al. (55) had shown unchanged elastin
content and slight alterations in glycosaminoglycons in
lungs of beagle dogs exposed to inhaled radionuclides.
Primary pulmonary hemangiosarcomas, with wide-
spread disseminated metastases, occurred with rela-
tively large doses (23,000 to 48,000 rad) of protracted
beta radiation to the lung (81). Bronchioloalveolar
carcinomas were the most common pulmonary neo-
plasms at lower dose levels (7,000 to 20,000 rad),
delivered in shorter intervals (79). As with inhaled
insoluble plutonium, pulmonary neoplasms were the
predominating cause ofdeath from inhaled beta-gamma
emitters, but pulmonary neoplasms occurred less than 2
years after exposure-earlier than after inhaled plu-
tonium. The difference in tumor types may reflect
differences in biological responses between the very
short-range, high-LET, alpha irradiation and the longer
range, low-LET beta-gamma irradiation.
Extrapulmonary lesions often play important roles in
inhalation exposure of dogs to radionuclides (6). They
include some degree of cardiomegaly and congestive
heartfailureindogswithpulmonaryfibrosis; prominent,
sclerosing, tracheobronchial lymphadenopathy resulting
from insoluble radionuclides being cleared by the lymph
nodes; and neoplasms in other organs that accumulate
radionuclides or, in the case of beta-gamma emitters
(79), are exposed to irradiation. Occasionally, dogs
with plutonium-induced lung tumors have developed hy-
pertrophic osteoarthropathy (76). Dose-related lympho-
penia, as well as evidence of decreased immunologic
competence, has been observed in dogs exposed to
insoluble radionuclides that concentrate in tracheo-
bronchial lymph nodes (82).
Mice
The mouse has been infrequently used as a model for
pulmonary radionuclide carcinogenesis. Temple et al.
(83)describedabronchiolarcarcinomaandtwosquamous
carcinomas in mice given 239PuO2 by intratracheal
injection. A reduction in the incidence of urethan-
induced pulmonary adenomas after inhaled 239PuO2 was
reported by Brightwell and Heppleston (84). After
repeatedly exposing mice to a relatively insoluble form
of 144Ce, giving dose rates and cumulative doses to the
lung comparable to those produced in dogs, the total
incidence oflungtumors was correlated with cumulative
dose, not dose rate (85).
Baboons
Studies with inhaled transuranics in baboons seem a
logical step for the extrapolation of nonprimate animal
data to man (86). The lesions in the lungs of baboons
following 239PuO2 inhalation were described as more
homogeneous than expected with particulates, and
consisted of interstitial pneumonitis, with fibrosis rich
in elastic fibers, hyalinized arteries, intense prolifer-
ation of Type II pneumocytes and foci of giant cell
interstitial pneumonia (78). However, the acute mor-
tality observed primarily reflecting the radiation pneu-
monitis was similar to that of dogs (87). The studies in
baboons have not progressed long enough to evaluate
possible long-term effects such as lung tumors.
Discussion
Studies on pulmonary effects of radionuclides have
used many animal models to study basic mechanisms
with which the lung responds to injury Phagocytosis of
inhaled or intratracheally injected particles appears as
a common initial event. Mitosis-linked cell death is a
widespread phenomenon of radiation injury, and is
possibly the major response of cells to the physical
injury resulting from the radionuclide. This results in
cell death or small areas of necrosis, depending on the
concentration of particles and the local distribution.
Fibrosis, as a general response to cell death, tends to
sequester the source of irritation. Epithelial cell
proliferation may result from this fibrosis or, more
likely, mayoccurconcurrently asaresponse toradiation-
induced epithelial cell death. The stimulus for epithelial
cell proliferation and transformation in association with
fibrosis is not known and, at present, the existence of
such a stimulus is only speculative. The possibility
cannot be excluded that fibrosis may render the
proliferation of epithelial cells more susceptible to
chemical or physical carcinogenesis.
Despite differences in radionuclides, animal species
and experimental procedures, there are many similar-
ities intumortype and histopathology. The predominant
lungtumors described have been ofepithelial origin and
have been classified, in decreasing frequency of occur-RADIONUCLIDE INJURY TO THE LUNG 135
rence, as: adenocarcinoma, bronchioloalveolar carcin-
oma, epidermoid carcinoma and combined epidermoid
and adenocarcinoma. Mesotheliomas and fibrosarcomas
have been observed in rats but less commonly in other
species. Hemangiosarcomas were frequently observed
in dogs exposed to beta-gamma emitters, and in rats
exposed to alpha emitters. Neither oat cell tumors, nor
any other type of neurosecretory cell tumor, have been
inducedbyexposinglaboratoryanimalstoradionuclides,
in spite of the presence of small-cell carcinomas in
uranium miners (19,22,88).
Major advantages of animal models for studying
cellular injury resulting from radionuclide exposure are
the ability to relate actual dose and dose rate, instead of
merel-y exposure level, to biological effects. The actual
deposition of energy from radionuclides in lung tissue
can be estimated from clearance curves. Correlation of
biological effects with dose and dose rate allows for
greater reproducibility of experiments and for more
precisetestingofhypotheses. Stochasticmicrodosimetry
is being developed to estimate energy exposures to
individual cells.
To summarize, in animals exposed to high levels of
radionuclides, death occurs from a variety of lesions
characterized as radiation fibrosis. At low exposure
levels, but at levels higher than most human ex-
posures, longer survival allows the appearance of
pulmonary neoplasia. Extrapolation of animal findings
to people must be performed with caution. Ongoing
lifespan studies will allow better documentation of the
level of risk at very low exposure levels.
Thisworkwassupportedbythe U. S. Department ofEnergyunder
Contract No. DE-AC06-76RLO-1830.
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